Authors: MANDEL S MORELAND E LAFRANCHI S GARGOSKY S

Citation: S. Mandel et al., THE EFFECT OF GH THERAPY ON THE MOLECULAR-FORMS OF IGFBP IN GHD CHILDREN, Journal of investigative medicine, 44(1), 1996, pp. 153-153

Authors: GUEVARAAGUIRRE J ROSENBLOOM AL VASCONEZ O MARTINEZ V GARGOSKY S ROSENFELD RG

Citation: J. Guevaraaguirre et al., 2 YEARS TREATMENT OF GH RECEPTOR DEFICIENCY (GHRD) WITH IGF-I - COMPARISON OF 2 DOSE LEVELS, Pediatric research, 39(4), 1996, pp. 520-520

Authors: MANDEL S MORELAND E ROSENFELD R GARGOSKY S

Citation: S. Mandel et al., THE EFFECT OF OH THERAPY ON THE MOLECULAR-FORMS OF IGFBP IN GH DEFICIENT CHILDREN, Pediatric research, 39(4), 1996, pp. 539-539

Authors: LAMSON G GIUDICE LC COHEN P LIU F GARGOSKY S MULLER HL OH Y WILSON KF HINTZ RL ROSENFELD RG

Citation: G. Lamson et al., PROTEOLYSIS OF IGFBP-3 MAY BE A COMMON REGULATORY MECHANISM OF IGF ACTION INVIVO, Growth regulation, 3(1), 1993, pp. 91-95

Authors: VACCARELLO MA DIAMOND FB GUEVARAAGUIRRE J ROSENBLOOM AL FIELDER PJ GARGOSKY S COHEN P WILSON K ROSENFELD RG

Citation: Ma. Vaccarello et al., HORMONAL AND METABOLIC EFFECTS AND PHARMACOKINETICS OF RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I IN GROWTH-HORMONE RECEPTOR DEFICIENCY LARONSYNDROME, The Journal of clinical endocrinology and metabolism, 77(1), 1993, pp. 273-280